Advertisement

Topics

STAT Plus: 5 things to know about Sage’s must-win drug trials in postpartum depression

04:30 EDT 13 Sep 2017 | STAT

The startup faces a key test as it awaits data on an experimental drug for postpartum depression. The same drug just failed a clinical trial in epilepsy.

Original Article: STAT Plus: 5 things to know about Sage’s must-win drug trials in postpartum depression

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: 5 things to know about Sage’s must-win drug trials in postpartum depression"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...